Pooled Efficacy from Two Phase 3 Pivotal Trials (RELIEF AND RESILIENT) of TNX-102 SL, Cyclobenzaprine HCl Sublingual Tablets, in Patients with Fibromyalgia

View at publisher
Authors: Errol M Gould, Seth M. Lederman, Jean Engels, Gregory M. Sullivan
Cited by: 1

Fields of Study & Subjects

Fibromyalgia and Chronic Fatigue Syndrome Research Respiratory and Cough-Related Research Osteoarthritis Treatment and Mechanisms

Publication details

Journal / source
Pain Management Nursing
Publisher
Elsevier BV
Volume
27
Issue
2
Pages
e244–e245
Publication date
31 March 2026
Language
EN